DRIL-QUIP INC (DRQ)

US2620371045 - Common Stock

15.41  -0.56 (-3.51%)

After market: 15.41 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to DRQ. DRQ was compared to 59 industry peers in the Energy Equipment & Services industry. DRQ has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, DRQ is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

In the past year DRQ has reported negative net income.
In the past year DRQ had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: DRQ reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: DRQ reported negative operating cash flow in multiple years.

1.2 Ratios

DRQ's Return On Assets of -2.68% is on the low side compared to the rest of the industry. DRQ is outperformed by 74.19% of its industry peers.
The Return On Equity of DRQ (-3.17%) is worse than 70.97% of its industry peers.
With a Return On Invested Capital value of 0.68%, DRQ is not doing good in the industry: 79.03% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -2.68%
ROE -3.17%
ROIC 0.68%
ROA(3y)-4.28%
ROA(5y)-3.07%
ROE(3y)-4.81%
ROE(5y)-3.45%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 1.61%, DRQ is doing worse than 75.81% of the companies in the same industry.
Looking at the Gross Margin, with a value of 28.53%, DRQ is in line with its industry, outperforming 58.06% of the companies in the same industry.
DRQ's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.61%
PM (TTM) N/A
GM 28.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.44%
GM growth 5Y-1.51%

8

2. Health

2.1 Basic Checks

DRQ has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for DRQ has been increased compared to 1 year ago.
DRQ has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, DRQ has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 4.52 indicates that DRQ is not in any danger for bankruptcy at the moment.
The Altman-Z score of DRQ (4.52) is better than 91.94% of its industry peers.
There is no outstanding debt for DRQ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.52
ROIC/WACC0.08
WACC8.32%

2.3 Liquidity

DRQ has a Current Ratio of 5.60. This indicates that DRQ is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 5.60, DRQ belongs to the best of the industry, outperforming 95.16% of the companies in the same industry.
DRQ has a Quick Ratio of 3.98. This indicates that DRQ is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.98, DRQ belongs to the top of the industry, outperforming 95.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.6
Quick Ratio 3.98

5

3. Growth

3.1 Past

DRQ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1000.00%.
DRQ shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.77%.
The Revenue has been growing slightly by 1.97% on average over the past years.
EPS 1Y (TTM)-1000%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%433.33%
Revenue 1Y (TTM)29.77%
Revenue growth 3Y5.13%
Revenue growth 5Y1.97%
Sales Q2Q%34.3%

3.2 Future

Based on estimates for the next years, DRQ will show a very strong growth in Earnings Per Share. The EPS will grow by 67.14% on average per year.
Based on estimates for the next years, DRQ will show a quite strong growth in Revenue. The Revenue will grow by 12.73% on average per year.
EPS Next Y187.53%
EPS Next 2Y168.04%
EPS Next 3Y111.1%
EPS Next 5Y67.14%
Revenue Next Year20.38%
Revenue Next 2Y13.37%
Revenue Next 3Y10.52%
Revenue Next 5Y12.73%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DRQ. In the last year negative earnings were reported.
DRQ is valuated rather expensively with a Price/Forward Earnings ratio of 19.81.
DRQ's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. DRQ is more expensive than 79.03% of the companies in the same industry.
DRQ's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.99.
Industry RankSector Rank
PE N/A
Fwd PE 19.81

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DRQ indicates a slightly more expensive valuation: DRQ is more expensive than 66.13% of the companies listed in the same industry.
DRQ's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. DRQ is more expensive than 61.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 66.12
EV/EBITDA 8.54

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as DRQ's earnings are expected to grow with 111.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y168.04%
EPS Next 3Y111.1%

0

5. Dividend

5.1 Amount

No dividends for DRQ!.
Industry RankSector Rank
Dividend Yield N/A

DRIL-QUIP INC

NYSE:DRQ (9/6/2024, 8:08:58 PM)

After market: 15.41 0 (0%)

15.41

-0.56 (-3.51%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)08-01 2024-08-01/amc
Earnings (Next)10-24 2024-10-24/amc
Inst Owners1.09%
Inst Owner Change-98.92%
Ins Owners1.82%
Ins Owner Change-0.07%
Market Cap530.87M
Analysts48
Price Target28.9 (87.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-422.36%
Min EPS beat(2)-789.73%
Max EPS beat(2)-55%
EPS beat(4)0
Avg EPS beat(4)-291.04%
Min EPS beat(4)-789.73%
Max EPS beat(4)-55%
EPS beat(8)2
Avg EPS beat(8)-105.49%
EPS beat(12)2
Avg EPS beat(12)-107.98%
EPS beat(16)3
Avg EPS beat(16)-567.86%
Revenue beat(2)1
Avg Revenue beat(2)0.75%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)3.02%
Revenue beat(4)3
Avg Revenue beat(4)2.74%
Min Revenue beat(4)-1.53%
Max Revenue beat(4)5.56%
Revenue beat(8)4
Avg Revenue beat(8)0.17%
Revenue beat(12)5
Avg Revenue beat(12)-0.6%
Revenue beat(16)6
Avg Revenue beat(16)-1.34%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.77%
EPS NY rev (1m)-70.45%
EPS NY rev (3m)-70.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-0.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.81
P/S 1.12
P/FCF 66.12
P/OCF 14.76
P/B 0.62
P/tB 0.67
EV/EBITDA 8.54
EPS(TTM)-0.63
EYN/A
EPS(NY)0.78
Fwd EY5.05%
FCF(TTM)0.23
FCFY1.51%
OCF(TTM)1.04
OCFY6.77%
SpS13.77
BVpS24.75
TBVpS23.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.68%
ROE -3.17%
ROCE 0.86%
ROIC 0.68%
ROICexc 0.86%
ROICexgc 0.94%
OM 1.61%
PM (TTM) N/A
GM 28.53%
FCFM 1.69%
ROA(3y)-4.28%
ROA(5y)-3.07%
ROE(3y)-4.81%
ROE(5y)-3.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.44%
GM growth 5Y-1.51%
F-Score5
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 85.08%
Cap/Sales 5.89%
Interest Coverage 250
Cash Conversion 88.91%
Profit Quality N/A
Current Ratio 5.6
Quick Ratio 3.98
Altman-Z 4.52
F-Score5
WACC8.32%
ROIC/WACC0.08
Cap/Depr(3y)68.2%
Cap/Depr(5y)55.03%
Cap/Sales(3y)5.33%
Cap/Sales(5y)4.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1000%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%433.33%
EPS Next Y187.53%
EPS Next 2Y168.04%
EPS Next 3Y111.1%
EPS Next 5Y67.14%
Revenue 1Y (TTM)29.77%
Revenue growth 3Y5.13%
Revenue growth 5Y1.97%
Sales Q2Q%34.3%
Revenue Next Year20.38%
Revenue Next 2Y13.37%
Revenue Next 3Y10.52%
Revenue Next 5Y12.73%
EBIT growth 1Y247.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year823.58%
EBIT Next 3Y135.99%
EBIT Next 5Y81%
FCF growth 1Y157.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y680.33%
OCF growth 3YN/A
OCF growth 5Y-29.85%